DBV Technologies

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch DBVT and buy or sell other stocks, ETFs, and their options commission-free!

About DBVT

DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. 

CEO
Daniel Tassé
CEODaniel Tassé
Employees
109
Employees109
Headquarters
Chatillon, Hauts-de-France
HeadquartersChatillon, Hauts-de-France
Founded
2002
Founded2002
Employees
109
Employees109

DBVT Key Statistics

Market cap
233.20M
Market cap233.20M
Price-Earnings ratio
-1.45
Price-Earnings ratio-1.45
Dividend yield
—
Dividend yield—
Average volume
96.94K
Average volume96.94K
High today
$9.35
High today$9.35
Low today
$8.40
Low today$8.40
Open price
$8.61
Open price$8.61
Volume
72.76K
Volume72.76K
52 Week high
$9.59
52 Week high$9.59
52 Week low
$2.20
52 Week low$2.20
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.